Dialysis patients may get relief from high anemia drug doses
NCT ID NCT07160452
First seen Sep 30, 2025 · Last updated May 01, 2026 · Updated 22 times
Summary
This study tests whether adding levocarnitine injections to standard care can lower the amount of anemia medication needed by adults on long-term dialysis. About 94 participants aged 20-60 will receive either levocarnitine after each dialysis session or usual care alone for 6 months. The goal is to see if levocarnitine helps red blood cells work better, reducing drug doses, side effects, and costs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.